Gastroenteritis Clinical Trials

A listing of Gastroenteritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 57 clinical trials
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

crohn's disease
  • 22 views
  • 24 Sep, 2021
  • 336 locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
  • 1735 views
  • 24 Sep, 2021
  • 881 locations
A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

This study is designed to evaluate how the body processes and removes mirikizumab. The study will also evaluate safety and disease response in pediatric participants with UC taking mirikizumab. The study will last about 52 weeks and may include up to 17 visits.

janus kinase inhibitor
immunomodulators
mirikizumab
corticosteroids
  • 2 views
  • 25 Sep, 2021
  • 43 locations
A Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to assess the safety and efficacy of PRA023 in participants with moderately to severely active Ulcerative Colitis. The purpose of Cohort 2 of the study is to assess the safety and efficacy of PRA023 in participants with moderately to severely active ulcerative colitis who …

tumor necrosis factor
  • 0 views
  • 24 Sep, 2021
  • 5 locations
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

This study seeks to evaluate the safety and efficacy of brazikumab versus placebo (Stage I) and versus an active comparator (Stage 2) in participants with moderately to severely active CD and will include assessments of clinical response as demonstrated by improvement of symptoms and colonic mucosal appearance as observed on …

methotrexate
endoscopy
antibiotics
budesonide
azathioprine
  • 401 views
  • 20 Sep, 2021
  • 321 locations
Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis

Together with Crohn's disease (CD), ulcerative colitis (UC) is one of the major forms of inflammatory bowel diseases (IBD).Currently, no curative therapy is available, since the pathophysiology of this disease is incompletely understood (1-3) and clinical practice demonstrates that current therapies induce remission in subgroups of patients only. Scientific evidence …

prednisone
budesonide
crohn's disease
remission
azathioprine
  • 0 views
  • 19 Sep, 2021
  • 1 location
featured
Induction Study #1 of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of oral ozanimod as a potential induction treatment for subjects with moderately to severely active Crohn's Disease.

ileal disease
abdominal pain
endoscopy
corticosteroids
  • 25 views
  • 15 Sep, 2021
  • 69 locations
featured
Induction Study #2 of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of oral ozanimod as a potential induction treatment for subjects with moderately to severely active Crohn's Disease.

ileal disease
abdominal pain
endoscopy
corticosteroids
  • 0 views
  • 15 Sep, 2021
  • 69 locations
Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis

Prematurity is still one of the primary causes of death in children under 5. 1-2. According to the WHO, 60% of all preterm births occur in Asia, with the Philippines accounting for around 348,900 every year. 3. Necrotizing enterocolitis is one of the fatal complications (NEC) 3, 4. Preterm newborns …

  • 0 views
  • 12 Sep, 2021
  • 1 location
Mepo for EoE Study

Multi-center, randomized, double blind, parallel-arm, placebo controlled trial to determine whether mepolizumab is more effective than placebo for improving symptoms of dysphagia and decreasing esophageal eosinophil counts in adults and adolescents with active eosinophilic esophagitis after an initial 3 month treatment course, and will also assess the impact of an …

dysphagia
esophageal biopsy
eosinophilia
  • 47 views
  • 24 Sep, 2021
  • 6 locations